Structure of the connexin-43 gap junction channel in a putative closed state.

biochemistry chemical biology connexin-43 cryo-EM gap junction channel hemichannel human membrane protein molecular biophysics structural biology structure

Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
03 08 2023
Historique:
medline: 4 8 2023
pubmed: 3 8 2023
entrez: 3 8 2023
Statut: epublish

Résumé

Gap junction channels (GJCs) mediate intercellular communication by connecting two neighbouring cells and enabling direct exchange of ions and small molecules. Cell coupling via connexin-43 (Cx43) GJCs is important in a wide range of cellular processes in health and disease (Churko and Laird, 2013; Liang et al., 2020; Poelzing and Rosenbaum, 2004), yet the structural basis of Cx43 function and regulation has not been determined until now. Here, we describe the structure of a human Cx43 GJC solved by cryo-EM and single particle analysis at 2.26 Å resolution. The pore region of Cx43 GJC features several lipid-like densities per Cx43 monomer, located close to a putative lateral access site at the monomer boundary. We found a previously undescribed conformation on the cytosolic side of the pore, formed by the N-terminal domain and the transmembrane helix 2 of Cx43 and stabilized by a small molecule. Structures of the Cx43 GJC and hemichannels (HCs) in nanodiscs reveal a similar gate arrangement. The features of the Cx43 GJC and HC cryo-EM maps and the channel properties revealed by molecular dynamics simulations suggest that the captured states of Cx43 are consistent with a closed state.

Identifiants

pubmed: 37535063
doi: 10.7554/eLife.87616
pii: 87616
pmc: PMC10400079
doi:
pii:

Substances chimiques

Connexin 43 0
Ion Channels 0
GJA1 protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Swiss National Science Foundation
ID : 184951
Pays : Switzerland

Informations de copyright

© 2023, Qi, Acosta Gutierrez et al.

Déclaration de conflit d'intérêts

CQ, SA, PL, AO, DL, EB, DS, PP, NZ, MB, FG, VK No competing interests declared

Références

J Mol Graph. 1996 Dec;14(6):354-60, 376
pubmed: 9195488
Nat Methods. 2014 Jan;11(1):63-5
pubmed: 24213166
J Struct Biol. 2016 Jan;193(1):1-12
pubmed: 26592709
Protein Sci. 2010 Dec;19(12):2389-401
pubmed: 20945358
J Cell Sci. 2017 Nov 1;130(21):3619-3630
pubmed: 29025971
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
pubmed: 20383002
Elife. 2023 Aug 03;12:
pubmed: 37535063
Nat Methods. 2017 Apr;14(4):331-332
pubmed: 28250466
Nature. 2018 Dec;564(7736):372-377
pubmed: 30542154
Hum Mol Genet. 2015 Jan 1;24(1):243-50
pubmed: 25168385
J Chem Theory Comput. 2019 Jan 8;15(1):775-786
pubmed: 30525595
Physiology (Bethesda). 2013 May;28(3):190-8
pubmed: 23636264
Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11388-93
pubmed: 13130072
J Chem Theory Comput. 2008 Mar;4(3):435-47
pubmed: 26620784
FASEB J. 2010 Nov;24(11):4378-95
pubmed: 20634352
J Med Genet. 2004 Jan;41(1):60-7
pubmed: 14729836
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
Front Physiol. 2014 Sep 12;5:348
pubmed: 25309448
Acta Crystallogr D Biol Crystallogr. 2010 Jan;66(Pt 1):12-21
pubmed: 20057044
Nat Methods. 2013 Aug;10(8):755-8
pubmed: 23817071
J Psychopharmacol. 2010 Nov;24(11):1717-24
pubmed: 19493957
Biochim Biophys Acta Biomembr. 2018 Jan;1860(1):192-201
pubmed: 28457858
Mol Cell Proteomics. 2015 May;14(5):1400-10
pubmed: 25724911
Int J Mol Sci. 2021 Apr 23;22(9):
pubmed: 33922534
J Gen Physiol. 1997 Apr;109(4):491-507
pubmed: 9101407
Am J Physiol Heart Circ Physiol. 2004 Oct;287(4):H1762-70
pubmed: 15205174
FEBS Lett. 2014 Apr 17;588(8):1193-204
pubmed: 24561196
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Front Neurol. 2020 Jul 31;11:703
pubmed: 32849190
Am J Med Genet A. 2005 Feb 15;133A(1):58-60
pubmed: 15637728
Am J Physiol Cell Physiol. 2012 May 15;302(10):C1548-56
pubmed: 22422398
Gene. 2014 Apr 10;539(1):157-61
pubmed: 24508941
Hum Mutat. 2009 May;30(5):724-33
pubmed: 19338053
Nat Commun. 2016 Jan 12;7:8770
pubmed: 26753910
Structure. 2021 Sep 2;29(9):1040-1047.e3
pubmed: 34129834
Protein Sci. 2018 Jan;27(1):112-128
pubmed: 28836357
Protein Sci. 2021 Jan;30(1):70-82
pubmed: 32881101
Clin Genet. 2006 Jul;70(1):71-2
pubmed: 16813608
Hum Mutat. 2004 Mar;23(3):286
pubmed: 14974090
Biochim Biophys Acta. 2004 Mar 23;1662(1-2):42-60
pubmed: 15033578
J Cell Biol. 1987 Dec;105(6 Pt 1):2621-9
pubmed: 2826492
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):213-21
pubmed: 20124702
Mol Biol Cell. 2012 Sep;23(17):3312-21
pubmed: 22809623
Mutat Res. 2001 Aug 8;479(1-2):173-86
pubmed: 11470490
Elife. 2018 Nov 09;7:
pubmed: 30412051
Science. 2019 Apr 26;364(6438):389-394
pubmed: 31023924
J Mol Biol. 2021 Aug 20;433(17):166994
pubmed: 33865869
Cell Commun Signal. 2004 Jun 1;2(1):2
pubmed: 15171789
Nature. 2009 Apr 2;458(7238):597-602
pubmed: 19340074
Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13413-8
pubmed: 12370422
Biochim Biophys Acta Biomembr. 2018 Jan;1860(1):9-21
pubmed: 28693896
Proc Natl Acad Sci U S A. 1998 Feb 17;95(4):1852-7
pubmed: 9465106
Biochim Biophys Acta. 2012 Feb;1818(2):294-302
pubmed: 22001851
J Cell Sci. 2006 Feb 1;119(Pt 3):532-41
pubmed: 16418219
Cell Rep. 2020 Apr 21;31(3):107482
pubmed: 32320665
Nat Rev Drug Discov. 2018 Dec;17(12):905-921
pubmed: 30310236
Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2556-61
pubmed: 10706639
J Chem Phys. 2007 Jan 7;126(1):014101
pubmed: 17212484
Nat Methods. 2017 Jan;14(1):71-73
pubmed: 27819658
Sci Adv. 2020 Aug 28;6(35):eaba4996
pubmed: 32923625
Arch Ophthalmol. 2005 Oct;123(10):1422-6
pubmed: 16219735
Protein Sci. 2018 Jan;27(1):14-25
pubmed: 28710774
Am J Hum Genet. 2003 Feb;72(2):408-18
pubmed: 12457340
Nat Commun. 2020 Aug 28;11(1):4331
pubmed: 32859914
Science. 1999 Feb 19;283(5405):1176-80
pubmed: 10024245
J Cell Biol. 1963 Oct;19:201-21
pubmed: 14069795
J Microsc. 1993 Mar;169(3):375-382
pubmed: 33930978
J Struct Biol. 2012 Dec;180(3):519-30
pubmed: 23000701

Auteurs

Chao Qi (C)

Institute of Molecular Biology and Biophysics, ETH Zurich, Zurich, Switzerland.
Laboratory of Biomolecular Research, Paul Scherrer Institute, Villigen, Switzerland.

Silvia Acosta Gutierrez (S)

Institute for the Physics of Living Systems, Institute of Structural and Molecular Biology, University College London, London, United Kingdom.
Institute for Bioengineering of Catalunya (IBEC), The Barcelona Institute of Science and Technology, Barcelona, Spain.

Pia Lavriha (P)

Institute of Molecular Biology and Biophysics, ETH Zurich, Zurich, Switzerland.
Laboratory of Biomolecular Research, Paul Scherrer Institute, Villigen, Switzerland.

Alaa Othman (A)

Institute of Molecular Systems Biology, ETH Zurich, Zurich, Switzerland.

Diego Lopez-Pigozzi (D)

Department of Physics and Astronomy "G. Galilei", University of Padova, Padua, Italy.
Veneto Institute of Molecular Medicine (VIMM), Padua, Italy.

Erva Bayraktar (E)

Veneto Institute of Molecular Medicine (VIMM), Padua, Italy.

Dina Schuster (D)

Institute of Molecular Biology and Biophysics, ETH Zurich, Zurich, Switzerland.
Laboratory of Biomolecular Research, Paul Scherrer Institute, Villigen, Switzerland.
Institute of Molecular Systems Biology, ETH Zurich, Zurich, Switzerland.

Paola Picotti (P)

Institute of Molecular Systems Biology, ETH Zurich, Zurich, Switzerland.

Nicola Zamboni (N)

Institute of Molecular Systems Biology, ETH Zurich, Zurich, Switzerland.

Mario Bortolozzi (M)

Department of Physics and Astronomy "G. Galilei", University of Padova, Padua, Italy.
Veneto Institute of Molecular Medicine (VIMM), Padua, Italy.

Francesco Luigi Gervasio (FL)

Department of Chemistry, University College London, London, United Kingdom.
School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland.
ISPSO, University of Geneva, Geneva, Switzerland.

Volodymyr M Korkhov (VM)

Institute of Molecular Biology and Biophysics, ETH Zurich, Zurich, Switzerland.
Laboratory of Biomolecular Research, Paul Scherrer Institute, Villigen, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH